Clinical Trial Update: Anti-Mullerian Hormone (AMH) and Antral Follicle Count as Markers of Ovarian Reserve- Prospective Followup of Young Cancer Patients

View source ↗

Summary

Prospective follow-up study evaluating anti-Mullerian hormone and antral follicle count as markers of ovarian reserve in young cancer patients; the trial status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Infertility | Status: UNKNOWN